NCT06400173 Validation Of The Flemish Montreal Cognitive Assessment (MoCA) For Persons With Hearing Impairment
| NCT ID | NCT06400173 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Ghent |
| Condition | Dementia |
| Study Type | OBSERVATIONAL |
| Enrollment | 450 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2025-12-31 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The Montreal Cognitive Assessment (MoCA) is a screening test for detecting cognitive impairment that assesses several cognitive domains (attention and concentration, arithmetic and orientation, memory, etc.). The instructions as well as some test items of the MoCA are presented auditory (spoken). Consequently, performance on the MoCA may be co-dependent on hearing. Therefore, to rule out the possible negative influence of hearing loss on performance on the MoCA, a MoCA for individuals with hearing loss was recently developed. More specifically, the original MoCA was modified by providing the instructions audiovisually (spoken with visual support) as well as by replacing hearing-dependent items. Since replacing items may affect sensitivity and specificity, the MoCA for persons with hearing loss should be revalidated.
Eligibility Criteria
Inclusion Criteria: * Individuals aged 60 years or older * Individuals with normal vision (with lenses or glasses if needed) * Individuals with age-related hearing loss * Dutch-speaking individuals * Individuals capable of giving consent to participate in the study themselves * Individuals still residing in their own homes * Individuals with an official diagnosis of dementia (Alzheimer's, vascular, or mixed) or mild cognitive impairment. This inclusion criterion applies only to the group with cognitive impairment. Exclusion Criteria: For individuals without cognitive impairment, the following exclusion criteria apply: * (History of) neurological problems (brain tumor, epilepsy, history of stroke, etc.) * Use of influencing medication (e.g., Ritalin and antidepressants)